
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a leading manufacturer in the tissue and hygiene market, with over half of its sales derived from personal care and a significant portion from consumer tissue products. The company plans to enhance its market presence by integrating Kenvue's consumer health portfolio by the second half of 2026, further strengthening its diverse product offerings that include well-known brands such as Huggies and Kleenex. With a focus on ramping up innovation and an anticipated robust innovation pipeline for 2026, Kimberly-Clark is well-positioned to leverage new technology and enhance its competitive advantage in the industry.
Bears say
Kimberly-Clark has projected a -4.0% decline in organic sales for the third quarter of 2025, a significant reversal from prior expectations of +4.5%. Alongside this, the company's U.S. measured retail sales have also faced a decline of -2.7% for the same period, indicating ongoing challenges in its key market. Furthermore, earnings per share estimates have been revised downward, with forecasts for fiscal 2025 lowered from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, reflecting deteriorating financial performance expectations.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares